Showing results (931-940 of 989) with videos related to

Sort By:
Pageof 99
The American Journal of Tropical Medicine and Hygiene|November 2, 2023
Evaluation of the Performance of a 3D-Printed Smartphone-Based Retinal Imaging Device as a Screening Tool for Retinal Pathology in MozambiqueRosauro Varo, María Postigo, Rubao Bila, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2017
Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non-Small-Cell Lung CancerRamaswamy Govindan, Aleksandra Szczesna, Myung-Ju Ahn, et al.
Nature Chemistry|May 23, 2014
A mitochondrial pathway for biosynthesis of lipid mediatorsYulia Y Tyurina, Samuel M Poloyac, Vladimir A Tyurin, et al.
Terapevticheskii Arkhiv|May 31, 2016
[N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs]I G Kirillova, D S Novikova, T V Popkova, et al.
Nature Communications|December 20, 2025
SETD1A regulates psychiatric gene networks involved in genomic stability and synaptic function in rare and sporadic schizophreniaTomoyo Sawada, Arthur S Feltrin, Yanhong Wang, et al.
Nature Communications|May 25, 2024
Lipidome atlas of the adult human brainMaria Osetrova, Anna Tkachev, Waltraud Mair, et al.
International Journal of Molecular Sciences|November 13, 2025
Gene Expression and Fatty Acid Composition in Sea Buckthorn Seeds and Pulp During Fruit Development of Different VarietiesNataliya V Melnikova, Alexander A Arkhipov, Yury A Zubarev, et al.
ESMO Open|May 4, 2023
A phase II open-label trial of avelumab plus axitinib in previously treated non-small-cell lung cancer or treatment-naïve, cisplatin-ineligible urothelial cancerG Galffy, I Lugowska, E V Poddubskaya, et al.
The Lancet. Oncology|October 31, 2024
Camizestrant, a next-generation oral SERD, versus fulvestrant in post-menopausal women with oestrogen receptor-positive, HER2-negative advanced breast cancer (SERENA-2): a multi-dose, open-label, randomised, phase 2 trialMafalda Oliveira, Denys Pominchuk, Zbigniew Nowecki, et al.
Frontiers in Immunology|December 23, 2024
Remodeling of the chromatin landscape in peripheral blood cells in patients with severe Delta COVID-19Vasiliy E Akimov, Dmitriy I Tychinin, Olga A Antonova, et al.
Pageof 99